Versant Capital Management’s Quest Diagnostics DGX Stock Holding History

Versant Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Sell	820 -106	-11%	-$20.8K	0.02%	684
2026 Q1	$181K	Sell	926 -1,187	-56%	-$231K	0.02%	623
2025 Q4	$367K	Buy	2,113 +892	+73%	+$162K	0.05%	298
2025 Q3	$233K	Buy	1,221 +978	+402%	+$174K	0.03%	419
2025 Q2	$43.6K	Sell	243 -3	-1%	-$521	0.01%	1049
2025 Q1	$41.6K	Sell	246 -5	-2%	-$821	0.01%	946
2024 Q4	$37.9K	Buy	251 +194	+340%	+$30.2K	0.01%	693
2024 Q3	$8.85K	Hold	57	–	–	﹤0.01%	1096
2024 Q2	$7.8K	Buy	57 +12	+27%	+$1.64K	﹤0.01%	1077
2024 Q1	$5.99K	Hold	45	–	–	﹤0.01%	961
2023 Q4	$6.21K	Sell	45 -3	-6%	-$394	﹤0.01%	900
2023 Q3	$5.85K	Hold	48	–	–	﹤0.01%	924
2023 Q2	$6.75K	Hold	48	–	–	﹤0.01%	918
2023 Q1	$6.77K	Hold	48	–	–	﹤0.01%	847
2022 Q4	$7.51K	Hold	48	–	–	﹤0.01%	755
2022 Q3	$6K	Hold	48	–	–	﹤0.01%	775
2022 Q2	$6K	Hold	48	–	–	﹤0.01%	789
2022 Q1	$7K	Hold	48	–	–	﹤0.01%	775
2021 Q4	$8K	Hold	48	–	–	﹤0.01%	750
2021 Q3	$7K	Hold	48	–	–	﹤0.01%	783
2021 Q2	$6K	Sell	48 -39	-45%	-$5.11K	﹤0.01%	838
2021 Q1	$11K	Hold	87	–	–	﹤0.01%	752
2020 Q4	$10K	Hold	87	–	–	﹤0.01%	727
2020 Q3	$9K	Hold	87	–	–	﹤0.01%	690
2020 Q2	$9K	Sell	87 -6	-6%	-$636	﹤0.01%	659
2020 Q1	$7K	Sell	93 -4	-4%	-$414	﹤0.01%	655
2019 Q4	$10K	Sell	97 -44	-31%	-$4.59K	0.01%	693
2019 Q3	$15K	Hold	141	–	–	0.01%	555
2019 Q2	$14K	Sell	141 -38	-21%	-$3.65K	0.01%	593
2019 Q1	$16K	Sell	179 -6	-3%	-$520	0.01%	710
2018 Q4	$15K	Hold	185	–	–	0.01%	649
2018 Q3	$19K	Sell	185 -30	-14%	-$3.29K	0.01%	659
2018 Q2	$23K	Hold	215	–	–	0.01%	552
2018 Q1	$21K	Sell	215 -9	-4%	-$922	0.01%	596
2017 Q4	$22K	Hold	224	–	–	0.01%	609
2017 Q3	$20K	Sell	224 -3	-1%	-$318	0.01%	584
2017 Q2	$25K	Hold	227	–	–	0.01%	498
2017 Q1	$22K	Sell	227 -5	-2%	-$477	0.01%	543
2016 Q4	$21K	Buy	232 +22	+10%	+$1.9K	0.01%	568
2016 Q3	$17K	Sell	210 -5	-2%	-$420	0.01%	621
2016 Q2	$17K	Buy	215 +11	+5%	+$838	0.01%	583
2016 Q1	$14K	Buy	204 +28	+16%	+$1.88K	0.01%	639
2015 Q4	$12K	Buy	+176	New	+$11.8K	0.01%	674

Other funds holding DGX

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JWM

JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Versant Capital Management's DGX Position: Q2 2026 in Review

Versant Capital Management reduced its Quest Diagnostics (DGX) stake by 11% in Q2 2026, selling an estimated $20.8K and leaving 820 shares worth $174K. The position accounts for 0.02% of the portfolio, ranked #684.

Versant Capital Management first reported a position in DGX in Q4 2015 and has held it in 43 quarters since. The position peaked at $367K in Q4 2025. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Versant Capital Management held 820 shares of Quest Diagnostics worth $174K as of Q2 2026.
Versant Capital Management sold 106 Quest Diagnostics shares in Q2 2026, an estimated $20.8K.
Quest Diagnostics made up 0.02% of Versant Capital Management's portfolio in Q2 2026, its #684 holding.
Versant Capital Management first reported a position in Quest Diagnostics in Q4 2015 and has held it in 43 quarters since.
Versant Capital Management's Quest Diagnostics position peaked at $367K in Q4 2025.
152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.